4
Changes in Ownership
Traws Pharma, Inc. Filed Acc 0001415889-25-004727
Chief Executive Officer acquired 96,348 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CAUTREELS WERNER Chief Executive Officer | 2025-02-18 | Option exercise | +96,348 | $0.01 | $963 | 104,348 | D |
| Derivatives | |||||||
| CAUTREELS WERNER Chief Executive Officer | 2025-02-18 | Option exercise · Pre-Funded Warrant (right to buy) | −96,348 | 0 | D | ||
Loading xslF345X05/form4-02192025_110231.xml…